Liu, Hongtao http://orcid.org/0000-0002-3190-7807
Funding for this research was provided by:
UCCCC pilot grant, and University of Chicago Cancer Center Support Grant (CA014599)
Article History
Received: 6 January 2021
Accepted: 11 March 2021
First Online: 23 March 2021
Declarations
:
: Not applicable.
: The author gives consent for publication.
: Dr. Hongtao Liu had research support from Karyopharm and BMS, served at the advisory board meeting for Agios.